The global REMEDY registry highlights significant gaps in the implementation of evidence-based interventions for rheumatic heart disease, including underuse of secondary prophylaxis and anticoagulation.
Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications. There is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.
Zühlke et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: